| Q37419587 | A longitudinal study of risk factors for incident albuminuria in diabetic American Indians: the Strong Heart Study. |
| Q91676304 | Association of High Levels of Spot Urine Protein with High Blood Pressure, Mean Arterial Pressure and Pulse Pressure with the Development of Diabetic Chronic Kidney Dysfunction or Failure among Diabetic Patients. Statistical Regression Modeling to P |
| Q34095894 | Complications of diabetes: renal disease and promotion of self-management |
| Q35627938 | Cost-effective strategies in the prevention of diabetic nephropathy |
| Q85278398 | Diabetic nephropathy |
| Q41886415 | Diabetic nephropathy: evidence for renoprotection and practice |
| Q38895879 | Dihydropyridine calcium channel blockers and renal disease |
| Q42662434 | Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria |
| Q84978295 | Evidence-based practice guideline for the treatment of CKD |
| Q79610876 | Health economic implications of irbesartan treatment versus standard blood pressure control in patients with type 2 diabetes, hypertension and renal disease: a Hungarian analysis |
| Q35752881 | Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy |
| Q35170130 | Lessons from trials in hypertensive type 2 diabetic patients |
| Q41375165 | Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients |
| Q41494500 | Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus |
| Q33942365 | Lisinopril: a review of its use in congestive heart failure |
| Q26798436 | Management of diabetic renal disease |
| Q34825007 | Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy |
| Q34566315 | Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris |
| Q37368689 | Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study |
| Q33649627 | Renal protection and antihypertensive drugs: current status |
| Q35904809 | Slowing the progression of adult chronic kidney disease: therapeutic advances. |
| Q74299128 | The case for combining angiotensin-converting enzyme inhibitors and calcium-channel blockers |
| Q35087677 | Treatment of hypertension in diabetic patients with nephropathy |